Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in TRVI — Trevi Therapeutics, Inc.
CIK 1844645
SAN FRANCISCO, CA
Position in TRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$32,500,832
+$13,964,881 QoQ
Shares Held
1,742,672
+12.2% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
10.56%
of 13F equity value
Holder Rank
#26
of 216 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $291,774,212 across 12 Biotechnology names. TRVI ranks #3 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
1,425,470 | $82,862,571 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,265,283 | $33,175,720 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
This page
|
1,742,672 | $32,500,832 | |
| 4 | AVLN |
Avalyn Pharma Inc.
|
966,792 | $31,826,792 | |
| 5 | EVMN |
Evommune, Inc.
|
1,926,943 | $25,609,072 | |
| 6 | MPLT |
MapLight Therapeutics, Inc.
|
611,446 | $21,914,224 | |
| 7 | OCS |
Oculis Holding AG
|
1,506,250 | $20,891,687 | |
| 8 | IMNM |
Immunome Inc.
|
732,512 | $15,521,929 |
All Filings in TRVI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,500,832 | 1,742,672 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,535,951 | 1,553,726 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $15,734,910 | 1,256,782 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,499,555 | 1,256,782 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,269,221 | 1,146,110 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||